[CAS NO. ]  Antifungal agent 41

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS

Catalog
HY-151439
Brand
MCE
CAS
-

DESCRIPTION

Overview

MDL-
Molecular Weight638.14
Molecular FormulaC22H18Cl4N4Se2
SMILESClC1=CC=C(C([Se][Se]C(C2=CC=C(Cl)C=C2Cl)CN3C=CN=C3)CN4C=CN=C4)C(Cl)=C1

For research use only. We do not sell to patients.

Summary

Antifungal agent 41 (compound B01) is an antifungal agent . Antifungal agent 41 shows inhibitory effect on Candida albicans in virto and vivo. Antifungal agent 41 can be used for the research of invasive fungal infections [1] .


In Vitro

Antifungal agent 41 (0.25-128 μg/mL) shows antifungal activities to C.alb , C.alb (sc5314), C.gla , C.par , C.kru , C.zey , C.neo and A.f with MIC values of 2, 1, 8, 2, 8, 0.25, 4 and 1 μg/mL, respectively [1] .
Antifungal agent 41 (0-64 μg/mL; 24 h) shows antifungal activities against pathogenic fluconazole-resistant Candida albicans with MIC values of 2, 8, 4, 2 and 4 μg/mL for strain CaR, 17#, 632, 901 and 904, respectively [1] .
Antifungal agent 41 (0-64 μg/mL; 24 h) shows antifungal activities against Candida albicans with MFC value of 16, 8, 16, >64, 16, 2 and 4 μg/mL for C.alb , C.alb (sc5314), strain CaR, 17#, 632, 901 and 904, respectively [1] .
Antifungal agent 41 (0-1024 μg/mL; 1.5-24 h) inhibits C.alb ATCC SC5314 and CPCC400616 biofilms with SMIC 50 s of 0.5 μg/mL and 0.5-4 μg/mL, with SMIC 80 s of 4-32 μg/mL and 2-4 μg/mL, respectively [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay [1]

Cell Line: HL-60, MDA-MB-231 and PC-3 cell lines
Concentration: 0-100 μM
Incubation Time: 24 h
Result: Inhibited growth of HL-60, MDA-MB-231 and PC-3 cells with IC 50 s of 32.53, 6.25 and 1.43 μM, respectively.

In Vivo

Antifungal agent 4 (6-12 mg/kg; i.p. once daily for 5 days) shows in vivo antifungal effects [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice with C.alb ATCC SC5314 infection [1]
Dosage: 6 mg/kg and 12 mg/kg
Administration: Intraperitoneal injection; 6 mg/kg and 12mg/kg once daily; for 5 days
Result: Significantly reduced the kidney fungal burden of C.alb .

Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.